
Best strategy for DME treatment? The network meta-analysis of 21 randomized trials (1798 eyes) compared anti-VEGF monotherapy with combination therapies (laser or glucocorticoid). No significant differences in best-corrected visual acuity (BCVA) or central macular thickness (CMT) were observed at 6 or 12 months. However, rankings suggest that anti-VEGF combined with laser therapy may be the most effective treatment approach.
Like
Save
Share